BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29496425)

  • 1. Endoluminal high-dose-rate brachytherapy for locally recurrent or persistent esophageal cancer.
    Taggar AS; Pitter KL; Cohen GN; Schattner M; Gerdes H; Markowitz AJ; Ilson D; Brady P; Cuaron JJ; Goodman KA; Wu AJ
    Brachytherapy; 2018; 17(3):621-627. PubMed ID: 29496425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoluminal high-dose-rate brachytherapy for early stage and recurrent esophageal cancer in medically inoperable patients.
    Folkert MR; Cohen GN; Wu AJ; Gerdes H; Schattner MA; Markowitz AJ; Ludwig E; Ilson DH; Bains MS; Zelefsky MJ; Goodman KA
    Brachytherapy; 2013; 12(5):463-70. PubMed ID: 23434221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage high-dose-rate brachytherapy for esophageal cancer in previously irradiated patients: A retrospective analysis.
    Wong Hee Kam S; Rivera S; Hennequin C; Lourenço N; Chirica M; Munoz-Bongrand N; Gornet JM; Quéro L
    Brachytherapy; 2015; 14(4):531-6. PubMed ID: 25906950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose-rate endoluminal brachytherapy for primary and recurrent esophageal cancer : Experience from a large single-center cohort.
    Nicolay NH; Rademacher J; Oelmann-Avendano J; Debus J; Huber PE; Lindel K
    Strahlenther Onkol; 2016 Jul; 192(7):458-66. PubMed ID: 27245818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost.
    Brunner TB; Rupp A; Melzner W; Grabenbauer GG; Sauer R
    Strahlenther Onkol; 2008 Jan; 184(1):15-22. PubMed ID: 18188518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose-rate interstitial brachytherapy for the treatment of high-volume locally recurrent endometrial carcinoma.
    Huang K; D'Souza D; Patil N; Velker V; Leung E; Stitt L; Whiston F; Sugimoto A; McGee J; Prefontaine M
    Brachytherapy; 2016; 15(5):543-8. PubMed ID: 27475479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of post-treatment stenosis in cervical esophageal cancer undergoing high-dose radiotherapy.
    Kim JW; Kim TH; Kim JH; Lee IJ
    World J Gastroenterol; 2018 Feb; 24(7):862-869. PubMed ID: 29467556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of recurrent bronchial carcinoma: the role of high-dose-rate endoluminal brachytherapy.
    Hauswald H; Stoiber E; Rochet N; Lindel K; Grehn C; Becker HD; Debus J; Harms W
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):373-7. PubMed ID: 19836162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Prospective Study of Proton Beam Reirradiation for Esophageal Cancer.
    Fernandes A; Berman AT; Mick R; Both S; Lelionis K; Lukens JN; Ben-Josef E; Metz JM; Plastaras JP
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):483-487. PubMed ID: 26847847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial high-dose-rate brachytherapy as salvage treatment for locally recurrent prostate cancer after definitive radiation therapy: Toxicity and 5-year outcome.
    Jiang P; van der Horst C; Kimmig B; Zinsser F; Poppe B; Luetzen U; Juenemann KP; Dunst J; Siebert FA
    Brachytherapy; 2017; 16(1):186-192. PubMed ID: 28341011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy.
    Sharma V; Mahantshetty U; Dinshaw KA; Deshpande R; Sharma S
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):310-5. PubMed ID: 11872275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies.
    Gupta AK; Vicini FA; Frazier AJ; Barth-Jones DC; Edmundson GK; Mele E; Gustafson GS; Martinez AA
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1055-60. PubMed ID: 10192355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward four-dimensional image-guided adaptive brachytherapy in locally recurrent endometrial cancer.
    Fokdal L; Ørtoft G; Hansen ES; Røhl L; Pedersen EM; Tanderup K; Lindegaard JC
    Brachytherapy; 2014; 13(6):554-61. PubMed ID: 25056640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: Association between dose and late toxicity.
    Rose JN; Crook JM; Pickles T; Keyes M; Morris WJ
    Brachytherapy; 2015; 14(3):342-9. PubMed ID: 25727178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophageal brachytherapy: Institut Gustave Roussy's experience.
    Kissel M; Chirat E; Annede P; Burtin P; Fumagalli I; Bronsart E; Mignot F; Schernberg A; Dumas I; Haie-Meder C; Chargari C
    Brachytherapy; 2020; 19(4):499-509. PubMed ID: 32444283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
    Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
    Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results.
    Puthawala A; Nisar Syed AM; Gamie S; Chen YJ; Londrc A; Nixon V
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):354-62. PubMed ID: 11567809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple-tandem high-dose-rate brachytherapy for early-stage medically inoperable endometrial cancer: Initial report on acute toxicity and dosimetric comparison to stereotactic body radiation therapy.
    Kauffmann G; Wu T; Al-Hallaq H; Hasan Y
    Brachytherapy; 2017; 16(1):141-146. PubMed ID: 27866953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.